Skip to main content

CLEPIC 2025: Advances in Epigenetics, with a Focus on Clinical Progresses, Applied Technologies and Epitarget Therapeutics

Edited by:

Lucia Altucci, MD, PhD, Università degli Studi della Campania, Italy
Marianne Rots, PhD, University Medical Center Groningen, The Netherlands

Submission Status: Open   |   Submission Deadline: 20 January 2026 
 

Clinical Epigenetics and Epigenetics Communications are proud to publish the extended proceedings of CLEPIC 2025, an international conference covering the latest developments in the expansive field of epigenetics.

Submit to collection

Clinical Epigenetics

Epigenetics Communications

About the Collection

The CLEPIC 2025 Collection will showcase research presented at the Clinical Epigenetics International Conference (CLEPIC 2025), which covers the latest developments in the expansive field of epigenetics. The conference brings together researchers from the fields of molecular and clinical epigenetics, along with industry partners, ethicists, policy advisors, and other stakeholders operating in the epigenetic research and diagnostics markets.

This Collection aims to explore cutting-edge findings and innovative approaches that are shaping the future of epigenetics and its applications.

Clinical Epigenetics is devoted to the study of epigenetic principles and mechanisms as applied to human development, disease, diagnosis and treatment.

Epigenetics Communications is devoted to the study and critical analysis of epigenetic principles and mechanisms in basic research settings.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submissions of original research and review articles. Should you wish to submit a different article type, please read the submission guidelines (Clinical Epigenetics, Epigenetics Communications) to confirm that type is accepted by the journal you are submitting to. 

Articles for this Collection should be submitted via our submission system, Snapp (Clinical Epigenetics, Epigenetics Communications). Please, select the appropriate Collection title “CLEPIC 2025: Advances in Epigenetics, with a Focus on Clinical Progresses, Applied Technologies and Epitarget Therapeutics" under the “Details” tab during the submission stage.

Articles will undergo the standard peer-review process of the journal they are considered in (Clinical Epigenetics, Epigenetics Communications) and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.